Skip to content

Analysis of the stability of Implants with different macrogeometries

Comparative analysis of the initial stability of Dental Implants with different macrogeometries: in vivo study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-78dvhgs
Enrollment
Unknown
Registered
2025-10-03
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implants

Interventions

This is a randomized clinical trial of three groups of dental implants with different macrogeometries. The Duecone group consists of 20 patients receiving 20 Duecone implants, one implant per patient.

Sponsors

Márcio de Carvalho Formiga
Lead Sponsor
Universidade do Vale do Itajaí
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years old or more; systemic healthy; no contraindications for implant surgeries; no need for bone grafts; with at least one site in the need for implant supported rehabilitation; good oral health conditions;

Exclusion criteria

Exclusion criteria: smokers; diabetes; patients with history of use of bisphosphonates oral or endovenous; patients with the need for bone grafts; any type of systemic condition that would contraindicate oral surgeries;

Design outcomes

Primary

MeasureTime frame
It is expected to discover which type of macrogeometry of implants tested shows higher rates of initial primary stability, that is, at the time of implant installation.

Secondary

MeasureTime frame
The aim is to determine which of the tested implant macrogeometry types yields the highest initial primary stability rates according to the implant site. Bone densities in the jaws vary depending on the site. This analysis will be performed after appropriate statistical tests are used.

Countries

Brazil, United States

Contacts

Public ContactMárcio Formiga

Universidade do Vale do Itajaí

marciocformiga@gmail.com+55 (48) 99914-4508

Outcome results

None listed

Source: REBEC (via WHO ICTRP)